| (2,4,5-trichlorophenoxy)acetic acid | decreases expression | ISO | RGD:10733 | 6480464 | 2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of HSPA8 mRNA | CTD | PMID:18579281 |
| (R)-adrenaline | increases expression | EXP | | 6480464 | Epinephrine results in increased expression of HSPA8 protein | CTD | PMID:19464573 |
| (S)-amphetamine | increases expression | ISO | RGD:10733 | 6480464 | Dextroamphetamine results in increased expression of HSPA8 mRNA | CTD | PMID:12205029 |
| (S)-amphetamine | multiple interactions | ISO | RGD:10733 | 6480464 | SOD1 inhibits the reaction [Dextroamphetamine results in increased expression of HSPA8 mRNA] | CTD | PMID:12205029 |
| 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of HSPA8 mRNA | CTD | PMID:20551477 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:10733 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HSPA8 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:10733 | 6480464 | Ethinyl Estradiol results in increased expression of HSPA8 mRNA | CTD | PMID:17942748 PMID:16174780 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of HSPA8 mRNA | CTD | PMID:16174780 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:10733 | 6480464 | Ethinyl Estradiol results in increased expression of HSPA8 mRNA | CTD | PMID:16174780 PMID:17942748 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:10733 | 6480464 | Ethinyl Estradiol affects the expression of HSPA8 mRNA | CTD | PMID:17555576 |
| 17beta-estradiol | increases expression | ISO | RGD:736219 | 6480464 | Estradiol results in increased expression of HSPA8 mRNA | CTD | PMID:16514628 PMID:20106945 |
| 17beta-estradiol | increases expression | ISO | RGD:736219 | 6480464 | Estradiol results in increased expression of HSPA8 mRNA | CTD | PMID:14605097 more ... |
| 17beta-estradiol | affects expression | ISO | RGD:736219 | 6480464 | Estradiol affects the expression of HSPA8 mRNA | CTD | PMID:22574217 |
| 17beta-estradiol | increases expression | ISO | RGD:736219 | 6480464 | Estradiol results in increased expression of HSPA8 mRNA | CTD | PMID:20106945 PMID:16514628 |
| 1H-pyrazole | increases expression | ISO | RGD:10733 | 6480464 | pyrazole results in increased expression of HSPA8 mRNA | CTD | PMID:17945193 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10733 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HSPA8 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:10733 | 6480464 | Tetrachlorodibenzodioxin affects the expression of HSPA8 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of HSPA8 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10733 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HSPA8 mRNA | CTD | PMID:17942748 PMID:16467188 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HSPA8 protein | CTD | PMID:19201780 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HSPA8 protein | CTD | PMID:16548065 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10733 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HSPA8 mRNA | CTD | PMID:16467188 PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HSPA8 mRNA | CTD | PMID:11752688 |
| 2,4,6-trinitrotoluene | affects expression | EXP | | 6480464 | Trinitrotoluene affects the expression of HSPA8 mRNA | CTD | PMID:21346803 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of HSPA8 mRNA | CTD | PMID:21346803 |
| 2-methylcholine | affects expression | ISO | RGD:736219 | 6480464 | beta-methylcholine affects the expression of HSPA8 mRNA | CTD | PMID:21179406 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | affects localization | EXP | | 6480464 | Puromycin Aminonucleoside affects the localization of HSPA8 protein | CTD | PMID:1614035 |
| 3,4-methylenedioxymethamphetamine | decreases expression | ISO | RGD:10733 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of HSPA8 mRNA | CTD | PMID:20188158 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:736219 | 6480464 | decitabine results in increased expression of HSPA8 mRNA | CTD | PMID:19151715 |
| 5-aza-2'-deoxycytidine | affects methylation | ISO | RGD:736219 | 6480464 | decitabine affects the methylation of HSPA8 gene | CTD | PMID:17630775 |
| 5-fluorouracil | affects response to substance | ISO | RGD:736219 | 6480464 | HSPA8 protein affects the susceptibility to Fluorouracil | CTD | PMID:16217747 |
| 7,12-dimethyltetraphene | increases expression | ISO | RGD:10733 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in increased expression of HSPA8 mRNA | CTD | PMID:21785161 |
| 7H-xanthine | multiple interactions | EXP | | 6480464 | [Xanthine co-treated with XDH protein] results in decreased expression of HSPA8 protein | CTD | PMID:19464573 |
| 8-bromo-3',5'-cyclic AMP | decreases expression | ISO | RGD:736219 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of HSPA8 mRNA | CTD | PMID:22079614 |
| 9H-xanthine | multiple interactions | EXP | | 6480464 | [Xanthine co-treated with XDH protein] results in decreased expression of HSPA8 protein | CTD | PMID:19464573 |
| acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of HSPA8 protein | CTD | PMID:15081597 |
| acrylamide | multiple interactions | EXP | | 6480464 | Tacrolimus inhibits the reaction [Acrylamide results in decreased expression of HSPA8 protein] | CTD | PMID:15081597 |
| afimoxifene | decreases expression | ISO | RGD:736219 | 6480464 | 4-hydroxytamoxifen results in decreased expression of HSPA8 mRNA; more ... | CTD | PMID:16514628 |
| albendazole | multiple interactions | ISO | RGD:736219 | 6480464 | [Ivermectin co-treated with Albendazole] results in increased expression of HSPA8 mRNA | CTD | PMID:16861626 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:736219 | 6480464 | Tretinoin results in decreased expression of HSPA8 mRNA | CTD | PMID:17218384 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of HSPA8 mRNA | CTD | PMID:16483693 |
| apigenin | decreases expression | ISO | RGD:10733 | 6480464 | Apigenin results in decreased expression of HSPA8 mRNA; more ... | CTD | PMID:22359648 |
| Aroclor 1254 | increases expression | ISO | RGD:736219 | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of HSPA8 mRNA | CTD | PMID:17851650 |
| arsenic atom | multiple interactions | ISO | RGD:10733 | 6480464 | [APOE protein affects the susceptibility to Arsenic] which results in increased expression of HSPA8 mRNA | CTD | PMID:22719926 |
| arsenic atom | increases expression | ISO | RGD:10733 | 6480464 | Arsenic results in increased expression of HSPA8 mRNA | CTD | PMID:22956628 |
| arsenite(3-) | increases oxidation | ISO | RGD:736219 | 6480464 | arsenite results in increased oxidation of HSPA8 protein | CTD | PMID:20196163 |
| astemizole | increases expression | EXP | | 6480464 | Astemizole results in increased expression of HSPA8 mRNA | CTD | PMID:20221588 |
| bathocuproine disulfonic acid | multiple interactions | ISO | RGD:736219 | 6480464 | [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of HSPA8 mRNA; more ... | CTD | PMID:15477007 |
| benzene | increases expression | ISO | RGD:736219 | 6480464 | Benzene results in increased expression of HSPA8 mRNA | CTD | PMID:21843810 |
| benzo[a]pyrene | increases expression | ISO | RGD:736219 | 6480464 | Benzo(a)pyrene results in increased expression of HSPA8 mRNA | CTD | PMID:20498004 |
| benzo[a]pyrene | increases expression | ISO | RGD:10733 | 6480464 | Benzo(a)pyrene results in increased expression of HSPA8 mRNA | CTD | PMID:21569818 PMID:22342234 |
| benzo[a]pyrene | increases expression | ISO | RGD:10733 | 6480464 | Benzo(a)pyrene results in increased expression of HSPA8 mRNA | CTD | PMID:21569818 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10733 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of HSPA8 mRNA | CTD | PMID:21715664 |
| bifenthrin | decreases expression | ISO | RGD:736219 | 6480464 | bifenthrin results in decreased expression of HSPA8 protein | CTD | PMID:16271832 |
| bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of HSPA8 mRNA | CTD | PMID:21318169 |
| bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:10733 | 6480464 | Diethylhexyl Phthalate results in increased expression of HSPA8 mRNA | CTD | PMID:21318169 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of HSPA8 protein | CTD | PMID:15229138 |
| bromobenzene | affects binding | EXP | | 6480464 | bromobenzene metabolite binds to HSPA8 protein | CTD | PMID:17305373 |
| C60 fullerene | increases expression | EXP | | 6480464 | fullerene C60 results in increased expression of HSPA8 mRNA | CTD | PMID:19167457 |
| cadmium dichloride | increases expression | ISO | RGD:10733 | 6480464 | Cadmium Chloride results in increased expression of HSPA8 mRNA | CTD | PMID:15081267 |
| cadmium sulfate | increases expression | ISO | RGD:736219 | 6480464 | cadmium sulfate results in increased expression of HSPA8 mRNA | CTD | PMID:21783983 |
| chloroprene | increases expression | ISO | RGD:10733 | 6480464 | Chloroprene results in increased expression of HSPA8 mRNA | CTD | PMID:23125180 |
| chlorpyrifos | decreases expression | ISO | RGD:10733 | 6480464 | Chlorpyrifos results in decreased expression of HSPA8 mRNA | CTD | PMID:20350560 |
| choline | multiple interactions | ISO | RGD:10733 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of HSPA8 gene | CTD | PMID:20938992 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:10733 | 6480464 | Ciguatoxins affects the expression of HSPA8 mRNA | CTD | PMID:18353800 |
| cisplatin | increases expression | ISO | RGD:736219 | 6480464 | Cisplatin results in increased expression of HSPA8 protein | CTD | PMID:21924258 |
| cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of HSPA8 mRNA | CTD | PMID:7626009 |
| cobalt dichloride | increases expression | ISO | RGD:736219 | 6480464 | cobaltous chloride results in increased expression of HSPA8 mRNA | CTD | PMID:19320972 |
| copper atom | multiple interactions | ISO | RGD:736219 | 6480464 | [Copper binds to N'-((2-hydroxyphenyl)carbonothioyl)pyridine-2-carbohydrazide] which results in increased expression of HSPA8 protein | CTD | PMID:16600465 |
| copper atom | affects binding | ISO | RGD:736219 | 6480464 | HSPA8 protein binds to Copper | CTD | PMID:14534351 PMID:15359738 |
| copper atom | affects binding | ISO | RGD:736219 | 6480464 | HSPA8 protein binds to Copper | CTD | PMID:15359738 |
| copper atom | increases expression | ISO | RGD:736219 | 6480464 | Copper results in increased expression of HSPA8 mRNA | CTD | PMID:16629173 |
| copper(0) | multiple interactions | ISO | RGD:736219 | 6480464 | [Copper binds to N'-((2-hydroxyphenyl)carbonothioyl)pyridine-2-carbohydrazide] which results in increased expression of HSPA8 protein | CTD | PMID:16600465 |
| copper(0) | affects binding | ISO | RGD:736219 | 6480464 | HSPA8 protein binds to Copper | CTD | PMID:14534351 PMID:15359738 |
| copper(0) | affects binding | ISO | RGD:736219 | 6480464 | HSPA8 protein binds to Copper | CTD | PMID:15359738 |
| copper(0) | increases expression | ISO | RGD:736219 | 6480464 | Copper results in increased expression of HSPA8 mRNA | CTD | PMID:16629173 |
| copper(2+) sulfate | increases expression | ISO | RGD:736219 | 6480464 | Copper Sulfate results in increased expression of HSPA8 mRNA | CTD | PMID:20599845 |
| copper(2+) sulfate | decreases expression | ISO | RGD:10733 | 6480464 | Copper Sulfate results in decreased expression of HSPA8 mRNA | CTD | PMID:18579281 |
| copper(2+) sulfate | affects expression | ISO | RGD:736219 | 6480464 | Copper Sulfate affects the expression of HSPA8 mRNA | CTD | PMID:19549813 |
| copper(2+) sulfate | decreases expression | ISO | RGD:736219 | 6480464 | Copper Sulfate results in decreased expression of HSPA8 mRNA | CTD | PMID:20599845 |
| cyclophosphamide | affects response to substance | ISO | RGD:736219 | 6480464 | HSPA8 protein affects the susceptibility to Cyclophosphamide | CTD | PMID:16217747 |
| cyclosporin A | increases expression | ISO | RGD:736219 | 6480464 | Cyclosporine results in increased expression of HSPA8 mRNA | CTD | PMID:20106945 |
| dasatinib (anhydrous) | affects binding | ISO | RGD:736219 | 6480464 | dasatinib binds to HSPA8 protein | CTD | PMID:18180381 |
| Delta(9)-tetrahydrocannabinol | decreases expression | ISO | RGD:10733 | 6480464 | Tetrahydrocannabinol results in decreased expression of HSPA8 mRNA; more ... | CTD | PMID:18584336 |
| Delta(9)-tetrahydrocannabinol | decreases expression | ISO | RGD:736219 | 6480464 | Tetrahydrocannabinol results in decreased expression of HSPA8 mRNA | CTD | PMID:16039398 PMID:18454173 |
| Delta(9)-tetrahydrocannabinol | decreases expression | ISO | RGD:736219 | 6480464 | Tetrahydrocannabinol results in decreased expression of HSPA8 mRNA | CTD | PMID:18454173 PMID:16039398 |
| dexamethasone | increases expression | ISO | RGD:10733 | 6480464 | Dexamethasone results in increased expression of HSPA8 mRNA | CTD | PMID:17998272 |
| diarsenic trioxide | increases expression | ISO | RGD:736219 | 6480464 | arsenic trioxide results in increased expression of HSPA8 protein | CTD | PMID:19364129 |
| diazoxide | decreases expression | ISO | RGD:10733 | 6480464 | Isoproterenol results in decreased expression of HSPA8 mRNA | CTD | PMID:20003209 |
| dibutyl phthalate | increases expression | ISO | RGD:10733 | 6480464 | Dibutyl Phthalate results in increased expression of HSPA8 mRNA | CTD | PMID:21266533 |
| diethyl maleate | increases reduction | ISO | RGD:10733 | 6480464 | diethyl maleate results in increased reduction of HSPA8 protein | CTD | PMID:19843705 |
| dimethylarsinic acid | decreases expression | ISO | RGD:10733 | 6480464 | Cacodylic Acid results in decreased expression of HSPA8 mRNA | CTD | PMID:17441966 |
| dimethylarsinic acid | multiple interactions | ISO | RGD:10733 | 6480464 | OGG1 protein inhibits the reaction [Cacodylic Acid results in decreased expression of HSPA8 mRNA] | CTD | PMID:17441966 |
| disodium selenite | increases expression | ISO | RGD:736219 | 6480464 | Sodium Selenite results in increased expression of HSPA8 mRNA | CTD | PMID:18175754 |
| diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of HSPA8 mRNA | CTD | PMID:21551480 |
| doxorubicin | multiple interactions | ISO | RGD:736219 | 6480464 | [Doxorubicin co-treated with pluronic block copolymer p85] results in increased expression of HSPA8 mRNA | CTD | PMID:16579640 |
| doxorubicin | increases expression | ISO | RGD:736219 | 6480464 | Doxorubicin results in increased expression of HSPA8 mRNA | CTD | PMID:16579640 PMID:17680992 |
| doxorubicin | increases expression | ISO | RGD:736219 | 6480464 | Doxorubicin results in increased expression of HSPA8 mRNA | CTD | PMID:17680992 PMID:16579640 |
| fenofibrate | increases expression | ISO | RGD:10733 | 6480464 | Fenofibrate results in increased expression of HSPA8 mRNA | CTD | PMID:21318169 |
| fenofibrate | multiple interactions | ISO | RGD:10733 | 6480464 | PPARA protein affects the reaction [Fenofibrate results in increased expression of HSPA8 mRNA] | CTD | PMID:21318169 |
| ferric oxide | multiple interactions | ISO | RGD:10733 | 6480464 | [Magnetite Nanoparticles co-treated with ferric oxide] results in increased expression of HSPA8 mRNA | CTD | PMID:20540983 |
| folic acid | multiple interactions | ISO | RGD:10733 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of HSPA8 gene | CTD | PMID:20938992 |
| formetanate | decreases expression | ISO | RGD:736219 | 6480464 | formetanate results in decreased expression of HSPA8 protein | CTD | PMID:16271832 |
| fulvestrant | decreases expression | ISO | RGD:736219 | 6480464 | fulvestrant results in decreased expression of HSPA8 mRNA | CTD | PMID:16514628 |
| furan | affects binding | EXP | | 6480464 | furan binds to HSPA8 protein | CTD | PMID:22240984 |
| furan | increases expression | ISO | RGD:10733 | 6480464 | furan results in increased expression of HSPA8 mRNA | CTD | PMID:20194422 |
| gamma-poly(L-glutamic acid) macromolecule | affects localization | EXP | | 6480464 | Polyglutamic Acid affects the localization of HSPA8 protein | CTD | PMID:10469394 |
| hyaluronic acid | multiple interactions | EXP | | 6480464 | Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of HSPA8 protein] | CTD | PMID:23178681 |
| hyaluronic acid | decreases expression | EXP | | 6480464 | Hyaluronic Acid analog results in decreased expression of HSPA8 protein | CTD | PMID:23178681 |
| hydralazine | multiple interactions | ISO | RGD:736219 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of HSPA8 mRNA | CTD | PMID:17183730 |
| hydrogen peroxide | affects expression | ISO | RGD:736219 | 6480464 | Hydrogen Peroxide affects the expression of HSPA8 mRNA | CTD | PMID:21179406 |
| hydrogen peroxide | decreases expression | EXP | | 6480464 | Hydrogen Peroxide results in decreased expression of HSPA8 protein | CTD | PMID:23178681 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of HSPA8 protein] | CTD | PMID:23178681 |
| hydroxyurea | increases expression | ISO | RGD:736219 | 6480464 | Hydroxyurea results in increased expression of HSPA8 mRNA | CTD | PMID:18647660 |
| ibuprofen | affects localization | ISO | RGD:736219 | 6480464 | Ibuprofen affects the localization of HSPA8 protein | CTD | PMID:16239242 PMID:14706622 |
| ibuprofen | affects localization | ISO | RGD:736219 | 6480464 | Ibuprofen affects the localization of HSPA8 protein | CTD | PMID:14706622 PMID:16239242 |
| imipramine | increases expression | EXP | | 6480464 | Imipramine results in increased expression of HSPA8 protein alternative form; more ... | CTD | PMID:10425221 |
| indomethacin | affects localization | ISO | RGD:736219 | 6480464 | Indomethacin affects the localization of HSPA8 protein | CTD | PMID:16239242 PMID:14706622 |
| indomethacin | affects localization | ISO | RGD:736219 | 6480464 | Indomethacin affects the localization of HSPA8 protein | CTD | PMID:14706622 PMID:16239242 |
| indomethacin | affects localization | ISO | RGD:10733 | 6480464 | Indomethacin affects the localization of HSPA8 protein | CTD | PMID:14706622 |
| ionomycin | multiple interactions | ISO | RGD:736219 | 6480464 | pyrrolidine dithiocarbamic acid promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HSPA8 mRNA]; more ... | CTD | PMID:15477007 |
| iron atom | multiple interactions | EXP | | 6480464 | [Nickel co-treated with Iron co-treated with Tungsten] results in increased expression of HSPA8 mRNA | CTD | PMID:22198552 |
| isoprenaline | decreases expression | ISO | RGD:10733 | 6480464 | Isoproterenol results in decreased expression of HSPA8 mRNA | CTD | PMID:20003209 |
| ivermectin | multiple interactions | ISO | RGD:736219 | 6480464 | [Ivermectin co-treated with Albendazole] results in increased expression of HSPA8 mRNA | CTD | PMID:16861626 |
| L-methionine | multiple interactions | ISO | RGD:10733 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of HSPA8 gene | CTD | PMID:20938992 |
| lead diacetate | decreases expression | ISO | RGD:10733 | 6480464 | lead acetate results in decreased expression of HSPA8 mRNA | CTD | PMID:21829687 |
| lead diacetate | affects expression | ISO | RGD:10733 | 6480464 | lead acetate affects the expression of HSPA8 protein | CTD | PMID:20797405 |
| lovastatin | increases expression | ISO | RGD:10733 | 6480464 | Lovastatin results in increased expression of HSPA8 mRNA | CTD | PMID:20493250 |
| maneb | multiple interactions | ISO | RGD:10733 | 6480464 | [Paraquat co-treated with Maneb] results in increased expression of HSPA8 mRNA | CTD | PMID:18386188 |
| manganese atom | multiple interactions | ISO | RGD:736219 | 6480464 | [Manganese binds to N'-((2-hydroxyphenyl)carbonothioyl)pyridine-2-carbohydrazide] which results in increased expression of HSPA8 protein | CTD | PMID:16600465 |
| manganese(0) | multiple interactions | ISO | RGD:736219 | 6480464 | [Manganese binds to N'-((2-hydroxyphenyl)carbonothioyl)pyridine-2-carbohydrazide] which results in increased expression of HSPA8 protein | CTD | PMID:16600465 |
| methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of HSPA8 protein | CTD | PMID:19826936 |
| methomyl | decreases expression | ISO | RGD:736219 | 6480464 | Methomyl results in decreased expression of HSPA8 protein | CTD | PMID:16271832 |
| methotrexate | affects expression | ISO | RGD:10733 | 6480464 | Methotrexate affects the expression of HSPA8 mRNA | CTD | PMID:18502557 |
| microcystin-LR | increases expression | ISO | RGD:10733 | 6480464 | cyanoginosin LR results in increased expression of HSPA8 mRNA | CTD | PMID:17654400 |
| mitomycin C | multiple interactions | ISO | RGD:736219 | 6480464 | Mitomycin promotes the reaction [TP53 protein results in increased expression of HSPA8 mRNA] | CTD | PMID:18647660 |
| mitomycin C | increases expression | ISO | RGD:736219 | 6480464 | Mitomycin results in increased expression of HSPA8 mRNA | CTD | PMID:18647660 |
| monocrotaline | multiple interactions | ISO | RGD:10733 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of HSPA8 mRNA | CTD | PMID:21224054 |
| morphine | increases expression | EXP | | 6480464 | Morphine results in increased expression of HSPA8 mRNA | CTD | PMID:15497504 |
| N-methylformamide | increases expression | ISO | RGD:10733 | 6480464 | methylformamide analog results in increased expression of HSPA8 mRNA; more ... | CTD | PMID:17040096 |
| nickel atom | multiple interactions | EXP | | 6480464 | [Nickel co-treated with Iron co-treated with Tungsten] results in increased expression of HSPA8 mRNA | CTD | PMID:22198552 |
| nickel dichloride | decreases expression | ISO | RGD:736219 | 6480464 | nickel chloride results in decreased expression of HSPA8 mRNA | CTD | PMID:17312168 |
| nitrofurantoin | increases expression | EXP | | 6480464 | Nitrofurantoin results in increased expression of HSPA8 mRNA | CTD | PMID:7626009 |
| ozone | decreases expression | ISO | RGD:10733 | 6480464 | Ozone results in decreased expression of HSPA8 mRNA | CTD | PMID:17095637 |
| ozone | increases expression | ISO | RGD:10733 | 6480464 | Ozone results in increased expression of HSPA8 mRNA | CTD | PMID:21543283 |
| paracetamol | affects expression | ISO | RGD:10733 | 6480464 | Acetaminophen affects the expression of HSPA8 mRNA | CTD | PMID:15606129 PMID:17562736 |
| paracetamol | increases expression | ISO | RGD:736219 | 6480464 | Acetaminophen results in increased expression of HSPA8 mRNA | CTD | PMID:21420995 |
| paracetamol | multiple interactions | ISO | RGD:10733 | 6480464 | PTGS2 protein affects the reaction [Acetaminophen results in increased expression of HSPA8 mRNA] | CTD | PMID:11743745 |
| paracetamol | increases expression | ISO | RGD:10733 | 6480464 | Acetaminophen results in increased expression of HSPA8 mRNA | CTD | PMID:11743745 |
| paracetamol | affects expression | ISO | RGD:10733 | 6480464 | Acetaminophen affects the expression of HSPA8 mRNA | CTD | PMID:17562736 PMID:15606129 |
| paraquat | multiple interactions | ISO | RGD:10733 | 6480464 | [Paraquat co-treated with Maneb] results in increased expression of HSPA8 mRNA | CTD | PMID:18386188 |
| perfluorooctane-1-sulfonic acid | increases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in increased expression of HSPA8 mRNA | CTD | PMID:21318169 |
| perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of HSPA8 mRNA | CTD | PMID:19162173 |
| perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of HSPA8 mRNA | CTD | PMID:19162173 PMID:21318169 |
| perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of HSPA8 mRNA | CTD | PMID:21318169 PMID:19162173 |
| phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of HSPA8 mRNA | CTD | PMID:19162173 |
| phenobarbital | affects expression | ISO | RGD:10733 | 6480464 | Phenobarbital affects the expression of HSPA8 mRNA | CTD | PMID:23091169 |
| phenytoin | multiple interactions | ISO | RGD:10733 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of HSPA8 mRNA | CTD | PMID:21224054 |
| phlorizin | increases expression | ISO | RGD:10733 | 6480464 | Phlorhizin results in increased expression of HSPA8 mRNA | CTD | PMID:22538082 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:736219 | 6480464 | bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HSPA8 mRNA]] | CTD | PMID:15477007 |
| phorone | increases expression | EXP | | 6480464 | phorone results in increased expression of HSPA8 mRNA | CTD | PMID:7626009 |
| pirimicarb | decreases expression | ISO | RGD:736219 | 6480464 | pirimicarb results in decreased expression of HSPA8 protein | CTD | PMID:16271832 |
| pirinixic acid | decreases expression | ISO | RGD:10733 | 6480464 | pirinixic acid results in decreased expression of HSPA8 mRNA | CTD | PMID:17426115 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of HSPA8 mRNA | CTD | PMID:21318169 PMID:19162173 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of HSPA8 mRNA | CTD | PMID:19162173 PMID:21318169 |
| pirinixic acid | multiple interactions | ISO | RGD:10733 | 6480464 | PPARA protein affects the reaction [pirinixic acid results in increased expression of HSPA8 mRNA] | CTD | PMID:21318169 |
| pirinixic acid | increases expression | ISO | RGD:10733 | 6480464 | pirinixic acid results in increased expression of HSPA8 mRNA | CTD | PMID:21318169 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of HSPA8 mRNA | CTD | PMID:19162173 |
| pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of HSPA8 mRNA | CTD | PMID:19162173 |
| pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of HSPA8 mRNA | CTD | PMID:19162173 PMID:21318169 |
| pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of HSPA8 mRNA | CTD | PMID:21318169 PMID:19162173 |
| propiconazole | increases expression | ISO | RGD:10733 | 6480464 | propiconazole results in increased expression of HSPA8 mRNA | CTD | PMID:21278054 PMID:19363144 |
| propiconazole | increases expression | ISO | RGD:10733 | 6480464 | propiconazole results in increased expression of HSPA8 mRNA | CTD | PMID:19363144 PMID:21278054 |
| prostaglandin A1 | increases metabolic processing | ISO | RGD:10733 | 6480464 | prostaglandin A1 analog results in increased metabolism of HSPA8 protein | CTD | PMID:19800325 |
| pyrogallol | increases expression | ISO | RGD:10733 | 6480464 | Pyrogallol results in increased expression of HSPA8 mRNA | CTD | PMID:20362636 |
| pyrogallol | multiple interactions | ISO | RGD:10733 | 6480464 | Silymarin inhibits the reaction [Pyrogallol results in increased expression of HSPA8 mRNA] | CTD | PMID:20362636 |
| quinolin-8-ol | affects localization | ISO | RGD:736219 | 6480464 | Oxyquinoline affects the localization of HSPA8 protein | CTD | PMID:16239242 |
| raloxifene | decreases expression | ISO | RGD:736219 | 6480464 | Raloxifene results in decreased expression of HSPA8 mRNA | CTD | PMID:16514628 |
| rifampicin | multiple interactions | ISO | RGD:10733 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of HSPA8 mRNA | CTD | PMID:21224054 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | increases expression | EXP | | 6480464 | Buthionine Sulfoximine results in increased expression of HSPA8 mRNA | CTD | PMID:7626009 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | increases expression | ISO | RGD:10733 | 6480464 | Buthionine Sulfoximine results in increased expression of HSPA8 mRNA | CTD | PMID:15707499 |
| sertraline | increases expression | EXP | | 6480464 | Sertraline results in increased expression of HSPA8 protein alternative form; more ... | CTD | PMID:10425221 |
| sevoflurane | affects expression | EXP | | 6480464 | sevoflurane affects the expression of HSPA8 mRNA | CTD | PMID:15967596 |
| silicon dioxide | increases expression | ISO | RGD:10733 | 6480464 | Silicon Dioxide results in increased expression of HSPA8 mRNA | CTD | PMID:19073995 |
| simvastatin | decreases expression | EXP | | 6480464 | Simvastatin results in decreased expression of HSPA8 protein | CTD | PMID:20217863 |
| tacrolimus hydrate | multiple interactions | EXP | | 6480464 | Tacrolimus inhibits the reaction [Acrylamide results in decreased expression of HSPA8 protein] | CTD | PMID:15081597 |
| tacrolimus hydrate | increases expression | EXP | | 6480464 | Tacrolimus results in increased expression of HSPA8 protein | CTD | PMID:15081597 |
| tamoxifen | affects expression | ISO | RGD:10733 | 6480464 | Tamoxifen affects the expression of HSPA8 mRNA | CTD | PMID:17555576 |
| titanium dioxide | increases expression | ISO | RGD:10733 | 6480464 | titanium dioxide results in increased expression of HSPA8 mRNA | CTD | PMID:23409001 |
| trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of HSPA8 mRNA | CTD | PMID:14565619 |
| trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of HSPA8 mRNA | CTD | PMID:19448997 |
| troglitazone | increases expression | ISO | RGD:10733 | 6480464 | troglitazone results in increased expression of HSPA8 protein | CTD | PMID:18495193 |
| tungsten atom | multiple interactions | EXP | | 6480464 | [Nickel co-treated with Iron co-treated with Tungsten] results in increased expression of HSPA8 mRNA | CTD | PMID:22198552 |
| valproic acid | multiple interactions | ISO | RGD:736219 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of HSPA8 mRNA | CTD | PMID:17183730 |
| valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of HSPA8 mRNA | CTD | PMID:21318169 |
| zinc pyrithione | increases expression | ISO | RGD:736219 | 6480464 | zinc pyrithione results in increased expression of HSPA8 mRNA | CTD | PMID:21424779 |
| zinc sulfate | affects localization | ISO | RGD:736219 | 6480464 | Zinc Sulfate affects the localization of HSPA8 protein | CTD | PMID:16239242 |